EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Moderna, Inc. $MRNA Shares Acquired by Empowered Funds LLC
Moderna (MRNA) Q2 2026 Earnings Call Transcript
The Flu Shot Is Entering a New Era, and It Could Change What's Next
Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations
Lazard Asset Management LLC Acquires Shares of 11,364 Moderna, Inc. $MRNA
FDA Approves New, More Effective Flu Vaccine From Moderna
Moderna Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today
FDA approves Moderna's mFlu vaccine for adults 50 and older
Moderna (MRNA) Wins Flu Vaccine Approval, Is It Fully Priced?
Moderna gets U.S. FDA approval for Influenza Vaccine mFLUSIVA
Moderna's new mRNA flu vaccine, explained | Vox
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine
FDA approves Moderna's first mRNA flu vaccine mFlusiva
FDA approves first mRNA flu vaccine after reversing its own rejection
FDA says yes to Moderna's mRNA flu vaccine
FDA approves Moderna's new mRNA flu vaccine - NBC Los Angeles
Trump denies weapons shortage reports; FAA investigates Marine One close call
FDA Approves First-Ever mRNA Flu Vaccine For Adults 50 And Older
FDA approves Moderna's mRNA-based vaccine: What you need to know
FDA Approves the First mRNA Flu Vaccine
FDA approves new mRNA-based flu vaccine
Moderna (MRNA) Stock Climbs After FDA Greenlights First mRNA Flu Vaccine mFLUSIVA
5 Things to Know Before the Stock Market Opens on Thursday
Tech Selloff Continues: AppLovin, Western Digital, and SanDisk Shares Plummet Thursday
The mRNA Revolution Moves Beyond COVID as FDA Clears First Sea...
US futures steady as Iran negotiations, earnings and economic data dominate attention: Dow Jones, S&P, Nasdaq, Wall Street
US futures trade mixed as investors assess Iran talks and fresh earnings: Dow Jones, S&P, Nasdaq, Wall Street
Edgestream Partners L.P. Sells 28,698 Shares of Moderna, Inc. $MRNA
U.S. FDA approves first mRNA flu shot from Moderna
FDA Approves First mRNA Flu Vaccine For Older Adults
Moderna, Inc. (NASDAQ:MRNA) Given Average Recommendation of "Reduce" by Analysts
FDA approves Moderna's mRNA flu vaccine after initial pushback - CBS News
FDA approves first mRNA-based flu vaccine
Moderna's mRNA Flu Shot Wins US Approval in FDA Turnaround
US FDA approves first mRNA flu shot from Moderna
FDA Approves First mRNA Flu Shot - Slashdot
From flu to duo: Moderna shot OK'd, melanoma data next | BioWorld
Are Wall Street Analysts Predicting Moderna Stock Will Climb or Sink?
Moderna, Inc. $MRNA Shares Bought by Quantinno Capital Management LP
Moderna FY2028 EPS Cut by Brookline Capital Markets - Markets Daily
Canada authorises clinical trials of Moderna Ebola vaccine
Moderna begins Phase 1 clinical trial of Ebola vaccine to help fight outbreak
Prediction: These 2 Stocks Will Keep Winning No Matter What the Market Does
Moderna starts Phase 1 trial of mRNA Bundibugyo Ebola vaccine
Health Canada approves clinical trial for Moderna's mRNA Ebola vaccine
Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus | Morningstar
Moderna begins first human trial of Bundibugyo Ebola vaccine
Moderna Begins Trial of Experimental Ebola Vaccine in Canada
Moderna Q2 EPS Raised by Brookline Capital Markets
Sei Investments Co. Acquires 55,939 Shares of Moderna, Inc. $MRNA
Hamilton Wealth LLC Cuts Stake in Moderna, Inc. $MRNA
Militia Capital Management LLC Buys New Shares in Moderna, Inc. $MRNA
Amundi Reduces Holdings in Moderna, Inc. $MRNA
Hamilton Wealth LLC Sells 24,338 Shares of Moderna, Inc. $MRNA - Stock Observer
FY2028 EPS Estimates for Moderna Decreased by Analyst
Moderna Target of Unusually Large Options Trading (NASDAQ:MRNA)
Moderna (MRNA) Faces Norovirus Setback As MFLUSIVA FDA Decision Nears
Health Care Down on Rotation Out of Defense - Health Care Roundup | Morningstar
Moderna (NASDAQ:MRNA) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Moderna's Innovation With mRNA Technology Is Extending Beyond Vaccines Into Oncology | Morningstar
Moderna Inc (MRNA) (Q2 2026) Earnings Call Highlights: Revenue Beat and Pipeline Progress Amid ...
Moderna adds new cohort to Phase III vaccine trial after interim data miss
Fusion's best-funded bet raised another $1bn, and hired the banker who took Moderna public
Moderna Q2 Earnings Call Highlights
Moderna (MRNA) Stock Tumbles 6% Premarket Despite Improved Q2 Revenue Amid $782M Loss
Moderna beats quarterly revenue estimate
Moderna, Inc Q2 Loss Decreases
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - Daily Political
Moderna Q2 26 Earnings Conference Call At 8:00 AM ET
Moderna, Inc. $MRNA Shares Sold by South Dakota Investment Council - Markets Daily
Promising Biotech Stocks To Follow Today - July 31st - Daily Political
South Dakota Investment Council Trims Holdings in Moderna, Inc. $MRNA - Stock Observer
A Baby Died, and Sanofi Quietly Ended RSV Vaccine Trial. The Company Says Death Was Unrelated to the Vaccine
When will fusion power startup Commonwealth Fusion Systems go public?
Moderna (MRNA) Q2 Earnings: What To Expect
Hamilton Wealth LLC Has $12.30 Million Stock Position in Moderna, Inc. $MRNA - Markets Daily
Best Biotech Stocks To Watch Today - July 30th - Daily Political
Hamilton Wealth LLC Buys 137,118 Shares of Moderna, Inc. $MRNA - Stock Observer
Moderna (MRNA) to Release Quarterly Earnings on Friday - Daily Political
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
